HOPE Therapeutics announced signing a non-binding Letter of Intent, or LOI, for acquisition of its first Interventional Psychiatry Clinics in Florida. These clinics are seen as top performers and will form the Company’s foundation for growth in Florida. The clinics to be acquired are revenue generating and EBITDA positive, thus the acquisition is expected to be immediately accretive to both revenue and EBITDA for HOPE and NRx.